A new study examined the connection between Baltimore City’s needle exchange program and drug treatment programs
A new study examined the connection between Baltimore City’s needle exchange program and drug treatment programs.
Individuals who enter treatment programs for drug addiction were more likely to be HIV-positive females who use the Baltimore City needle exchange programs.The study by researchers at the Johns Hopkins Bloomberg School of Public Health highlights the need for treatment facilities to address co-occurring problems, such as HIV and mental illness. It is published in the December 2006 edition of the journal Substance Use & Misuse.
“Needle exchange programs and drug user treatment centers are two effective strategies to reduce HIV infections and drug abuse,” explained Carl A. Latkin, PhD, lead author of the study and a professor in the Bloomberg School of Public Health’s Department of Health, Behavior and Society.
“Needle exchange programs reduce the number of contaminated syringes in a community and drug treatment reduces drug use, which may indirectly reduce HIV transmission.”
In their analysis, the study authors included 440 injection drug users who were interviewed from 1997 to 2002 as part of the Self-Help in Eliminating Life-Threatening Diseases (SHIELD) study. At follow-up, 166 of the study participants were enrolled in methadone maintenance or detoxification, or a drug-free residential or outpatient treatment program.
Individuals who entered treatment programs were more likely to be female, unemployed and participants in Baltimore City’s needle exchange program, compared with individuals who did not enter drug treatment programs. Those in treatment were also more likely to be HIV positive, have a history of mental illness and inject heroin. Individuals who did not enter treatment programs were more likely to sniff or snort cocaine or heroin.
Advertisement
The study authors also point out the need to publicize the services offered by needle exchange programs beyond needle distribution and disposal.
Advertisement
Source-Eurekalert
SRI